Mettler-Toledo International, Inc. $MTD Shares Sold by Panagora Asset Management Inc.

Key Points

• Panagora Asset Management Inc. reduced its stake in Mettler-Toledo International, Inc. by 34.3%, selling 1,620 shares and holding a total of 3,100 shares valued at $3,661,000 as of the end of the most recent reporting period.
• Several institutional investors have increased their holdings in Mettler-Toledo International, with GAMMA Investing LLC expanding its stake by a remarkable 131,246.3%, now owning 386,158 shares worth $456 million.
• Mettler-Toledo International reported a Q2 earnings per share (EPS) of $10.09, exceeding analyst expectations of $9.58, while its revenue for the quarter rose 3.9% year-over-year.

Panagora Asset Management Inc. cut its position in Mettler-Toledo International, Inc. (NYSE:MTD - Free Report) by 34.3% in the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm owned 3,100 shares of the medical instruments supplier's stock after selling 1,620 shares during the quarter. Panagora Asset Management Inc.'s holdings in Mettler-Toledo International were worth $3,661,000 at the end of the most recent quarter.

A number of other hedge funds also recently added to or reduced their stakes in the stock. Greenleaf Trust lifted its position in Mettler-Toledo International by 1.2% during the 1st quarter. Greenleaf Trust now owns 872 shares of the medical instruments supplier's stock worth $1,030,000 after acquiring an additional 10 shares during the period. Brooklyn Investment Group lifted its position in Mettler-Toledo International by 12.8% during the 1st quarter. Brooklyn Investment Group now owns 88 shares of the medical instruments supplier's stock worth $104,000 after acquiring an additional 10 shares during the period. Albion Financial Group UT lifted its position in Mettler-Toledo International by 1.5% during the 1st quarter. Albion Financial Group UT now owns 754 shares of the medical instruments supplier's stock worth $890,000 after acquiring an additional 11 shares during the period. Sequoia Financial Advisors LLC lifted its position in Mettler-Toledo International by 1.8% during the 1st quarter. Sequoia Financial Advisors LLC now owns 627 shares of the medical instruments supplier's stock worth $740,000 after acquiring an additional 11 shares during the period. Finally, TD Private Client Wealth LLC lifted its position in Mettler-Toledo International by 5.4% during the 1st quarter. TD Private Client Wealth LLC now owns 214 shares of the medical instruments supplier's stock worth $253,000 after acquiring an additional 11 shares during the period. 95.07% of the stock is owned by institutional investors and hedge funds.

Insider Transactions at Mettler-Toledo International

In other news, Director Thomas P. Salice sold 1,062 shares of the firm's stock in a transaction on Wednesday, August 13th. The stock was sold at an average price of $1,300.90, for a total transaction of $1,381,555.80. Following the sale, the director owned 283 shares in the company, valued at $368,154.70. This trade represents a 78.96% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, CFO Shawn Vadala sold 300 shares of the firm's stock in a transaction on Tuesday, August 19th. The stock was sold at an average price of $1,325.00, for a total value of $397,500.00. Following the sale, the chief financial officer owned 5,095 shares in the company, valued at $6,750,875. This trade represents a 5.56% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 1,827 shares of company stock worth $2,371,208 over the last quarter. 1.94% of the stock is currently owned by insiders.

Mettler-Toledo International Price Performance

Mettler-Toledo International stock traded up $16.86 during mid-day trading on Friday, hitting $1,304.65. 95,040 shares of the company were exchanged, compared to its average volume of 128,164. The business's 50 day simple moving average is $1,251.17 and its two-hundred day simple moving average is $1,186.88. The company has a market capitalization of $26.88 billion, a P/E ratio of 33.04, a PEG ratio of 3.86 and a beta of 1.37. Mettler-Toledo International, Inc. has a 12-month low of $946.69 and a 12-month high of $1,521.01.

Mettler-Toledo International (NYSE:MTD - Get Free Report) last released its quarterly earnings results on Thursday, July 31st. The medical instruments supplier reported $10.09 earnings per share for the quarter, topping the consensus estimate of $9.58 by $0.51. The company had revenue of $983.22 million during the quarter, compared to the consensus estimate of $957.41 million. Mettler-Toledo International had a negative return on equity of 476.07% and a net margin of 21.46%.Mettler-Toledo International's revenue was up 3.9% compared to the same quarter last year. During the same quarter last year, the business posted $9.65 earnings per share. Mettler-Toledo International has set its FY 2025 guidance at 42.100-42.600 EPS. Q3 2025 guidance at 10.550-10.750 EPS. Equities research analysts predict that Mettler-Toledo International, Inc. will post 42.71 earnings per share for the current year.

Wall Street Analyst Weigh In

A number of analysts have weighed in on the company. Evercore ISI decreased their price objective on Mettler-Toledo International from $1,280.00 to $1,275.00 and set an "outperform" rating for the company in a research report on Monday, August 4th. Bank of America increased their target price on Mettler-Toledo International from $1,200.00 to $1,260.00 and gave the stock a "neutral" rating in a research note on Thursday, June 26th. Robert W. Baird increased their target price on Mettler-Toledo International from $1,210.00 to $1,230.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. UBS Group raised Mettler-Toledo International from a "neutral" rating to a "buy" rating and cut their target price for the stock from $1,530.00 to $1,350.00 in a research note on Tuesday, May 20th. Finally, Barclays began coverage on Mettler-Toledo International in a research note on Tuesday, June 24th. They issued an "overweight" rating and a $1,325.00 price objective for the company. Five equities research analysts have rated the stock with a Buy rating and five have given a Hold rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $1,311.11.

Mettler-Toledo International Profile

Mettler-Toledo International Inc manufactures and supplies precision instruments and services in the Americas, Europe, Asia, and internationally. It operates through five segments: U.S. Operations, Swiss Operations, Western European Operations, Chinese Operations, and Other. The company's laboratory instruments include laboratory balances, liquid pipetting solutions, automated laboratory reactors, real-time analytics, titrators, pH meters, process analytics sensors and analyzer technologies, physical value analyzers, density and refractometry, thermal analysis systems, and other analytical instruments; and LabX, a laboratory software platform to manage and analyze data generated from its instruments.